A continuous-flow left ventricular assist device (LVAD) improved survival free from disabling stroke compared with a pulsatile LVAD, when used as destination therapy over a 2-year period in patients ...
Angiotensin II antagonists may help prevent GI bleeding among heart failure patients with continuous-flow left ventricular assist devices (LVADs), a retrospective study suggested. Taking ACE ...
Their findings suggest that this new technology provides effective hemodynamic support... Left ventricular assist devices (LVADs) are often used in patients requiring heart transplantation, either as ...
The study involved 7 children weighing 8 kg to 30 kg; all children survived, 5 to transplant and 1 to recovery. HealthDay News — The Jarvik 2015 left ventricular assist device (LVAD) seems promising ...
On July 29, a team from Emory’s Heart and Vascular Center completed its 500th continuous flow, durable left ventricular assist device (LVAD) implantation, further affirming Emory Healthcare’s status ...
The HeartMate 3 (Abbott) left ventricular assist device (LVAD) can now be used in pediatric patients with advanced refractory left ventricular heart failure who are awaiting heart transplantation or ...
Please provide your email address to receive an email when new articles are posted on . “We sought to assess how the incidence of RHF changes over time after LVAD implantation and to determine the ...
Please provide your email address to receive an email when new articles are posted on . Machine learning models to predict myocardial recovery among patients who underwent left ventricular assist ...
Patients who developed late right heart failure (RHF) after left ventricular assist device (LVAD) surgery suffered more major adverse events and had worse survival, researchers found. At 1 month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results